Followers | 218 |
Posts | 38765 |
Boards Moderated | 0 |
Alias Born | 04/29/2008 |
Friday, August 26, 2016 8:15:37 AM
TA - Over $500 million in toxic funded pump and dumps exposed and growing every day!
Recent KALV News
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/02/2024 10:30:00 AM
- KalVista Pharmaceuticals Highlights Strategic Plans for Coming Fiscal Year • Business Wire • 05/01/2024 10:30:00 AM
- KalVista Pharmaceuticals Appoints William C. Fairey to Board of Directors • Business Wire • 04/22/2024 10:30:00 AM
- KalVista Pharmaceuticals to Present at 23rd Annual Needham Virtual Healthcare Conference • Business Wire • 04/03/2024 10:30:00 AM
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/02/2024 10:30:00 AM
- KalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas • Business Wire • 03/18/2024 10:30:00 AM
- KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat • Business Wire • 03/12/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:37:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/11/2024 08:26:19 PM
- KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update • Business Wire • 03/11/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:50:45 PM
- KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2024 HAEi Regional Conference Americas • Business Wire • 03/08/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:38:33 AM
- KalVista Pharmaceuticals Announces Appointment of Benjamin L. Palleiko as Chief Executive Officer • Business Wire • 03/07/2024 11:30:00 AM
- KalVista Pharmaceuticals to Participate in the Leerink Partners 2024 Global Biopharma Conference • Business Wire • 03/06/2024 11:30:00 AM
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/04/2024 11:30:00 AM
- KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting • Business Wire • 02/27/2024 11:30:00 AM
- KalVista Pharmaceuticals Presents Additional Phase 3 KONFIDENT Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting • Business Wire • 02/26/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:15:27 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/22/2024 06:22:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:51:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:48:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:46:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:44:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:41:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM